Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (421-430 of 524) with videos related to

Pageof 53
Sort By:
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
British Journal of Cancer|December 29, 2021
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancersYonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, et al.
Cancer|August 31, 2019
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancersMichael Offin, Daniel Feldman, Ai Ni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung CancerM Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
JTO Clinical and Research Reports|January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated TumorsAlissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
Nature Communications|April 20, 2022
Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenograftsRebecca Caeser, Jacklynn V Egger, Shweta Chavan, et al.
Molecular Cell|May 25, 2022
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1Wenjing Su, Radha Mukherjee, Rona Yaeger, et al.
Nature Immunology|May 1, 2023
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategiesAriella Glasner, Samuel A Rose, Roshan Sharma, et al.
Pageof 53

Showing results (421-430 of 524) with videos related to

Sort By:
Pageof 53
Nature Cancer|August 8, 2022
cfDNA methylome profiling for detection and subtyping of small cell lung cancersFrancesca Chemi, Simon P Pearce, Alexandra Clipson, et al.
British Journal of Cancer|December 29, 2021
Immune biomarkers and response to checkpoint inhibition of BRAF<sup>V600</sup> and BRAF non-V600 altered lung cancersYonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, et al.
Cancer|August 31, 2019
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancersMichael Offin, Daniel Feldman, Ai Ni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2018
Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung CancerM Catherine Pietanza, Saiama N Waqar, Lee M Krug, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
JTO Clinical and Research Reports|January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated TumorsAlissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
Nature Communications|April 20, 2022
Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenograftsRebecca Caeser, Jacklynn V Egger, Shweta Chavan, et al.
Molecular Cell|May 25, 2022
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1Wenjing Su, Radha Mukherjee, Rona Yaeger, et al.
Nature Immunology|May 1, 2023
Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategiesAriella Glasner, Samuel A Rose, Roshan Sharma, et al.
Pageof 53